Peter S. Green

Becton Dickinson, one of the world’s largest medical technology companies, said in a statement Tuesday it has entered into a definitive agreement to sell its surgical instrumentation platform to Steris, an Ohio-based medical device firm specializing…

Using artificial intelligence to examine dental X-rays can nearly double diagnostic accuracy, and help detect other diseases. Florian Hillen is a medical school dropout, artificial intelligence enthusiast, former MIT graduate student and Harvard…

The U.S. Food and Drug Administration has granted de novo clearance to the Cue COVID-19 Molecular Test, the first at-home, over-the-counter test for COVID-19 to use the traditional premarket review pathway.The authorization represents “a new era of…

Dive Brief: As many as 57,000 Evo ventilators are facing a voluntary recall by Philips over problems with the machines’ air flow sensor.The U.S. Food and Drug Administration has labeled the recall Class I, warning that filters must be changed…

The recall, tied to specific sets of the Impella 5.5 with SmartAssist, comes just months after Johnson & Johnson paid $16.6 billion for Abiomed The FDA said Monday that Abiomed, the heart device maker bought by Johnson & Johnson last year for $16.6…

The acquisition is aimed at strengthening Getinge’s position in the fast-growing area of custom single-use solutions for bioprocessing applications. Getinge, a Sweden-based maker of technology for hospital care, cardiovascular procedures and sterile…

The company is “confident in delivering durable revenue growth in the year ahead” amid continued improvements in procedure volumes. By the numbers Q4 Non-GAAP Net income: $2.1 billion Q4 Earnings per share (non-GAAP diluted): $1.57 FY2023 non-GAAP…

Manufacturing and supply chain “headwinds” hurt operating margins in the first quarter, the company said. By the numbers Q1 Healthcare adjusted operating income: $360 million Q1 Insights 3M, which makes wound care and dental products, said it will…

By the numbers Q1 Earnings per share (diluted): $3.32 Q1 Insights: Thermo Fisher Scientific, the world’s largest provider of scientific instruments and laboratory and diagnostic machines and materials, reported a 9% decline in first-quarter revenue…

LivaNova, a UK-based medical device maker, announced late Friday that its CEO, Damien McDonald, has resigned. At the same time, it reported preliminary first-quarter earnings that beat the expectations of analysts. The firm’s chairman, William Kozy,…

Readers for Abbott’s FreeStyle Libre glucose monitoring systems could catch fire if improperly stored or charged, FDA says. Abbott has initiated a recall for readers for its FreeStyle Libre glucose monitoring systems, which are at risk of catching…

Jakobs said he “hopes and expects” to reach a settlement with the Food and Drug Administration this year; settling suits over alleged medical damages may take longer. Philips is pushing for a settlement this year of the first in a series of…

The collapse last week of Silicon Valley Bank, a storied lender and financier of startups including some medtech companies, appears to have had a minimal effect on established firms in the sector, according to a survey by analysts at two banks that…

After beginning its European rollout last month, the UK-based device maker hopes to bring its market-leading position to the U.S. UK-based LivaNova said it received 510(k) clearance from the U.S. Food and Drug Administration for its Essenz Heart-Lung…

The court’s decision to let a lower court verdict stand leaves the company subject to varying state liability laws, J&J says. The move is a victory for California, the first state to go to trial against the company after thousands of U.S. women sued…

Companies flush with cash are looking for good investments and innovative products that can reduce procedure costs, industry observers say. Medtech companies hit the brakes on large mergers and acquisitions last year with 11 transactions valued above…

The company benefitted from “robust end-market demand, improved pricing, and easing supply chain pressures” in the period. By the numbers GE HealthCare, reporting earnings for its last time as a subsidiary of General Electric, posted an 8% gain in…

Leaders from across the medtech field weigh in on the prospects and challenges for product regulation in 2023. For medical device makers – and the patients who rely on them – 2023 is poised to be a year of challenge and change for regulation. A…

By the numbers Johnson & Johnson, the second-biggest medtech firm after Medtronic, said on an earnings call Tuesday that it expects the $16.6 billion acquisition of heart assist device maker Abiomed to add to earnings in 2024 as it positions the…

The head of a Stanford research team says the test differs from Theranos’ defunct product because “ours works.” Michael Snyder is chairman of the Department of Genetics at Stanford University, where he is also the director of the Center for Genomics…